The High “Cost” of Experimental Drugs Obtained Through Health Litigation in Brazil

The High “Cost” of Experimental Drugs Obtained Through Health Litigation in Brazil

BackgroundBrazilian patients have legal right to access unlicensed medicines undergoing clinical research, if there is evidence of efficacy and safety. This study investigated the occurrence of serious adverse events related to very high-cost medicines from clinical studies, expanded access and comp...

Full description

Bibliographic Details
Main Authors: Ricardo Eccard da Silva, Elisangela da Costa Lima, Maria Rita C. G. Novaes, Claudia G. S. Osorio-de-Castro
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Pharmacology
Subjects:
litigation
clinical trials
compassionate use
expanded access
adverse drug event
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.00752/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2020.00752/full

Similar Items